Editorial for the special issue on "microbiomes in extremes of aging".
Abstract
This special issue of the Journal of Experimental Gerontology explores the dynamic interplay between microbiomes and aging-related conditions. The four selected studies highlight the role of microbiota in Alzheimer's disease, cancer immunotherapy, myocardial infarction and tryptophan metabolism, providing insights into how microbiomes influence health and disease in aging. These studies underscore the potential for microbiome-targeted interventions to mitigate aging-related disorders and improve the quality of life for older adults.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper discusses the interplay between microbiomes and aging-related conditions, which is relevant to longevity research. However, it primarily focuses on specific diseases and their treatment rather than addressing the root causes of aging or lifespan extension. The insights provided may contribute to understanding aging-related disorders but do not represent a significant advancement in the field of longevity research. Thus, the impact score reflects a solid but limited contribution.
Author of this paper? Send a correction.